Oligomerization preceding amyloid fibril formation: a process in common to intrinsically disordered and globular proteins

References:

• Auer S, Dobson CM, Vendruscolo M. Characterization of the nucleation barriers for protein aggregation and amyloid formation. HFSP J 2007; 1: 137–146
   PubMed Web of Science ®Google Scholar
• Daizo H, Dobson CM. A Kinetic Study of b-Lactoglobulin Amyloid Fibril Formation Promoted by Urea. Protein Sci 2002; 11: 2417–2426
   PubMed Web of Science ®Google Scholar
• Di Giaimo R, Riccio M, Santi S, Galeotti C, Ambrosetti DC, Melli M. New insights into the molecular basis of progressive myoclonus epilepsy: A multiprotein complex with cystatin B. Hum Mol Genet 2002; 11: 2941–2950
   PubMed Web of Science ®Google Scholar
• Fandrich M, Fletcher MA, Dobson CM. Amyloid fibrils from muscle myoglobin. Nature 2001; 410: 165–166
   PubMed Web of Science ®Google Scholar
• Ferreira ST, De Felice FG. PABMB Lecture. Protein dynamics, folding and misfolding: From basic physical chemistry to human conformational diseases. FEBS Lett 2001; 498: 129–134
   PubMed Web of Science ®Google Scholar
• Glabe CG. Structural classification of toxic amyloid oligomers. J Biol Chem 2008; 283: 29639–29643
   PubMed Web of Science ®Google Scholar
• Guijarro JI, Sunde M, Jones JA, Campbell ID, Dobson CM. Amyloid Fibril Formation by an SH3 Domain. Proc. Natl. Acad. Sci USA 1998; 95: 4224–4228
   PubMed Web of Science ®Google Scholar
• Janowski R, Kozak M, Jankowska E, Grzonka Z, Grubb A, Abrahamson M, Jaskolski M. Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping. Nat Struct Biol 2001; 8: 316–320
   PubMedGoogle Scholar
• Jenko Kokalj S, Guncar G, Stern I, Morgan G, Rabzelj S, Kenig M, Staniforth RA, Waltho JP, Zerovnik E, Turk D. Essential role of proline isomerization in stefin B tetramer formation. J Mol Biol 2007; 366: 1569–1579
   PubMed Web of Science ®Google Scholar
• Jerala R, Zerovnik E. Accessing the global minimum conformation of stefin A dimer by annealing under partially denaturing conditions. J Mol Biol 1999; 291: 1079–1089
   PubMed Web of Science ®Google Scholar
• Kallberg Y, Gustafsson M, Persson B, Thyberg J, Johansson J. Prediction of amyloid fibril-forming proteins. J Biol Chem 2001; 276: 12945–12950
   PubMed Web of Science ®Google Scholar
• Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, Glabe CG. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 2003; 300: 486–489
   PubMed Web of Science ®Google Scholar
• Kenig M, Jenko-Kokalj S, Tusek-Znidaric M, Pompe-Novak M, Guncar G, Turk D, Waltho JP, Staniforth RA, Avbelj F, Zerovnik E. Folding and amyloid-fibril formation for a series of human stefins' chimeras: Any correlation?. Proteins 2006; 62: 918–927
   PubMed Web of Science ®Google Scholar
• Knaus KJ, Morillas M, Swietnicki W, Malone M, Surewicz WK, Yee VC. Crystal structure of the human prion protein reveals a mechanism for oligomerization. Nat Struct Biol 2001; 8: 770–774
   PubMedGoogle Scholar
• Knowles TP, Shu W, Devlin GL, Meehan S, Auer S, Dobson CM, Welland ME. Kinetics and thermodynamics of amyloid formation from direct measurements of fluctuations in fibril mass. Proc Natl Acad Sci USA 2007; 104: 10016–10021
   PubMed Web of Science ®Google Scholar
• Lalioti MD, Mirotsou M, Buresi C, Peitsch MC, Rossier C, Ouazzani R, Baldy-Moulinier M, Bottani A, Malafosse A, Antonarakis SE. Identification of mutations in cystatin B, the gene responsible for the Unverricht-Lundborg type of progressive myoclonus epilepsy (EPM1). Am J Hum Genet 1997; 60: 342–351
   PubMed Web of Science ®Google Scholar
• Linding R, Schymkowitz J, Rousseau F, Diella F, Serrano L. A comparative study of the relationship between protein structure and beta-aggregation in globular and intrinsically disordered proteins. J Mol Biol 2004; 342: 345–353
   PubMed Web of Science ®Google Scholar
• Liu Y, Eisenberg D. 3D domain swapping: As domains continue to swap. Protein Sci 2002; 11: 1285–1299
   PubMed Web of Science ®Google Scholar
• Miller KH, Karr JR, Marqusee S. A hinge region cis-proline in ribonuclease A acts as a conformational gatekeeper for C-terminal domain swapping. J Mol Biol 2010; 400: 567–578
   PubMed Web of Science ®Google Scholar
• Morgan GJ, Giannini S, Hounslow AM, Craven CJ, Zerovnik E, Turk V, Waltho JP, Staniforth RA. Exclusion of the native alpha-helix from the amyloid fibrils of a mixed alpha/beta protein. J Mol Biol 2008; 375: 487–498
   PubMed Web of Science ®Google Scholar
• Pennacchio LA, Lehesjoki AE, Stone NE, Willour VL, Virtaneva K, Miao JM, DAmato E, Ramirez L, Faham M, Koskiniemi M, et al. Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1). Science 1996; 271: 1731–1734
   PubMed Web of Science ®Google Scholar
• Rabzelj S, Turk V, Zerovnik E. In vitro study of stability and amyloid-fibril formation of two mutants of human stefin B (cystatin B) occurring in patients with EPM1. Protein Sci 2005; 14: 2713–2722
   PubMed Web of Science ®Google Scholar
• Ramirez-Alvarado M, Merkel JS, Regan L. A Systematic Exploration of the Influence of the Protein Stability on Amyloid Fibril Formation in Vitro. Proc. Natl. Acad. Sci USA 2000; 97: 8979–8984
   PubMed Web of Science ®Google Scholar
• Richardson JS, Richardson DC. Natural β-Sheet Proteins use Negative Design to Avoid Edge-to-Edge Aggregation. Proc. Natl. Acad. Sci USA 2002; 99: 2754–2759
   PubMed Web of Science ®Google Scholar
• Sabate R, Gallardo M, Estelrich J. Temperature dependence of the nucleation constant rate in beta amyloid fibrillogenesis. Int J Biol Macromol 2005; 35: 9–13
   PubMed Web of Science ®Google Scholar
• Sanders A, Jeremy Craven C, Higgins LD, Giannini S, Conroy MJ, Hounslow AM, Waltho JP, Staniforth RA. Cystatin forms a tetramer through structural rearrangement of domain-swapped dimers prior to amyloidogenesis. J Mol Biol 2004; 336: 165–178
   PubMed Web of Science ®Google Scholar
• Serag AA, Altenbach C, Gingery M, Hubbell WL, Yeates TO. Identification of a subunit interface in transthyretin amyloid fibrils: Evidence for self-assembly from oligomeric building blocks. Biochemistry-Us 2001; 40: 9089–9096
   PubMed Web of Science ®Google Scholar
• Skerget K, Taler-Vercic A, Bavdek A, Hodnik V, Ceru S, Tusek-Znidaric M, Kumm T, Pitsi D, Pompe-Novak M, Palumaa P, et al. Interaction between oligomers of stefin B and amyloid-beta in vitro and in cells. J Biol Chem 2010; 285: 3201–3210
   PubMed Web of Science ®Google Scholar
• Skerget K, Vilfan A, Pompe-Novak M, Turk V, Waltho JP, Turk D, Zerovnik E. The mechanism of amyloid-fibril formation by stefin B: Temperature and protein concentration dependence of the rates. Proteins 2009; 74: 425–436
   PubMed Web of Science ®Google Scholar
• Smajlovic A, Berbic S, Schiene-Fischer C, Tusek-Znidaric M, Taler A, Jenko-Kokalj S, Turk D, Zerovnik E. Essential role of Pro 74 in stefin B amyloid-fibril formation: Dual action of cyclophilin A on the process. FEBS Lett 2009; 583: 1114–1120
   PubMed Web of Science ®Google Scholar
• Staniforth RA, Giannini S, Higgins LD, Conroy MJ, Hounslow AM, Jerala R, Craven CJ, Waltho JP. Three-dimensional domain swapping in the folded and molten-globule states of cystatins, an amyloid-forming structural superfamily. EMBO J 2001; 20: 4774–4781
   PubMed Web of Science ®Google Scholar
• Stefani M. Biochemical and biophysical features of both oligomer/fibril and cell membrane in amyloid cytotoxicity. Febs J 2010; 277: 4602–4613
   PubMed Web of Science ®Google Scholar
• Suk JE, Lokappa SB, Ulmer TS. The clustering and spatial arrangement of beta-sheet sequence, but not order, govern alpha-synuclein fibrillogenesis. Biochemistry-Us 2010; 49: 1533–1540
   PubMed Web of Science ®Google Scholar
• Turk V, Stoka V, Turk D. Cystatins: Biochemical and structural properties, and medical relevance. Front Biosci 2008; 13: 5406–5420
   PubMed Web of Science ®Google Scholar
• Uversky VN. Amyloidogenesis of natively unfolded proteins. Curr Alzheimer Res 2008; 5: 260–287
   Google Scholar
• Uversky VN. Intrinsic disorder in proteins associated with neurodegenerative diseases. Front Biosci 2009a; 14: 5188–5238
   PubMed Web of Science ®Google Scholar
• Uversky VN. Intrinsically disordered proteins and their environment: Effects of strong denaturants, temperature, pH, counter ions, membranes, binding partners, osmolytes, and macromolecular crowding. Protein J 2009b; 28: 305–325
   PubMed Web of Science ®Google Scholar
• Uversky VN. Mysterious oligomerization of the amyloidogenic proteins. Febs J 2010; 277: 2940–2953
   PubMed Web of Science ®Google Scholar
• Uversky VN. Intrinsically disordered proteins from A to Z. Int J Biochem Cell Biol 2011; 43: 1090–1103
   PubMed Web of Science ®Google Scholar
• Uversky VN, Li J, Fink AL. Evidence for a partially folded intermediate in alpha-synuclein fibril formation. J Biol Chem 2001; 276: 10737–10744
   PubMed Web of Science ®Google Scholar
• Walsh DT, Montero RM, Bresciani LG, Jen AY, Leclercq PD, Saunders D, AN EL-A, Gbadamoshi L, Gentleman SM, Jen LS. Amyloid-beta peptide is toxic to neurons in vivo via indirect mechanisms. Neurobiol Dis 2002; 10: 20–27
   PubMed Web of Science ®Google Scholar
• Wu C, Shea JE. Coarse-grained models for protein aggregation. Curr Opin Struct Biol 2011; 21: 209–220
   PubMed Web of Science ®Google Scholar
• Zerovnik E, Skarabot M, Skerget K, Giannini S, Stoka V, Jenko-Kokalj S, Staniforth RA. Amyloid fibril formation by human stefin B: Influence of pH and TFE on fibril growth and morphology. Amyloid 2007; 14: 237–247
   PubMed Web of Science ®Google Scholar
• Zerovnik E, Staniforth RA, Turk D. Amyloid fibril formation by human stefins: Structure, mechanism & putative functions. Biochimie 2010; 92: 1597–1607
   PubMed Web of Science ®Google Scholar
• Zerovnik E, Stoka V, Mirtic A, Guncar G, Grdadolnik J, Staniforth RA, Turk D, Turk V. Mechanisms of amyloid fibril formation–focus on domain-swapping. Febs J 2011; 278: 2263–2282
   PubMed Web of Science ®Google Scholar